wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41457918-59837084-55A7-4875-A08E-7C27C268C4EC
Q41457918-59837084-55A7-4875-A08E-7C27C268C4EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41457918-59837084-55A7-4875-A08E-7C27C268C4EC
Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma.
P2860
Q41457918-59837084-55A7-4875-A08E-7C27C268C4EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41457918-59837084-55A7-4875-A08E-7C27C268C4EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5dad07723024ac73c6628ac392d210185a8e680e
P2860
A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma.